News / Finance
WhisperfromWallStreet.com "End of Day" Losers - Seven Arts Pictures PLC,SAPX - World Energy Solutions Inc (DE),XWES - GTC Biotherapeutics Inc,GTCBD
Seven Arts Pictures - World Energy Solutions - GTC Biotherapeutics
Seven Arts Pictures PLC,SAPX
Seven Arts Pictures plc, through its subsidiaries, engages in the production and licensing of motion pictures in the United Kingdom and internationally. It develops motion pictures for theatrical, video, and television. The company also provides a library of completed motion pictures for distribution and to deliver commissioned motion pictures; and loan financing facilities. As of June 30, 2008, it owned a library of approximately 32 motion pictures. Seven Arts Pictures plc has operations in Europe, North America, South America, Africa, the Middle East, Asia, and Australia. The company is based in London, the United Kingdom.
---
If you are viewing this press release you are obviously interested in making money in the stock market. In today’s market investors need every tool available. WhisperfromWallStreet.com sends FREE alerts to our subscribers on stocks that we feel are ready to move within hours or days. So far in 2009 we have sent 36 stock alerts to our clients and the average price gain has been 88%. To add additional profits to your portfolio please take a minute and sign up for our free alerts. There is no risk to you and you will see just how accurate we are in our alerts.
Investors sign up for our FREE alerts at http://whisperfromwallstreet.com
---
World Energy Solutions Inc (DE),XWES
World Energy Solutions, Inc., an operator of online exchanges for energy and green commodities, today announced Great Addresses, a leading independent Hotel Management Company in Washington, D.C., has successfully greened the energy portfolios of its flagship properties through transactions on the World Energy Exchange® and World Green Exchange®.
Great Addresses worked with World Energy to first secure a 36-month electricity contract, with 10% green power, for its premiere D.C. lodgings, The Carlyle Suites Hotel and The Savoy Suites Hotel. Then, spurred by the savings from that transaction, Great Addresses invested in a 3-year strip of Renewable Energy Certificates (RECs) on the World Green Exchange to green its entire energy purchase. As a result, the Carlyle Suites and Savoy Suites Hotels will effectively run on 100% wind power for the next three years.
---
GTC Biotherapeutics Inc,GTCBD
GTC Biotherapeutics, Inc. engages in the development and production of human therapeutic proteins through transgenic technology. The company is developing a portfolio of recombinant blood proteins based on its technology to treat a range of genetic and acquired blood deficiencies, including hemophilia and other blood coagulation disorders. Its product includes ATryn, a recombinant form of human antithrombin for the treatment of hereditary antithrombin deficiency (HD) patients undergoing surgery or childbirth. The company?s products in development stage comprise rhFVIIa, a recombinant human coagulation factor VIIa for the treatment of hemophilia; rhFIX, a recombinant human factor IX for the treatment of type B hemophilia; rhAAT, a recombinant form of human alpha-1 antitrypsin as an inhibitor of elastase; and CD20 MAb, an immune system receptor.
----
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
WhisperfromWallStreet.com (WFWS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by WFWS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WFWS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.whisperfromwallstreet.com or mentioned herein. WFWS may have been compensated with shares or with cash from third party shareholders or the company on behalf of one or more of the companies mentioned in this opinion.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WFWS undertakes no obligation to update such statements.
This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
CONTACT: WhisperFromWallStreet.com
